What should I Know Regarding Pregnancy, Nursing and Administering Emla 2.5 %-2.5 % Topical Cream to Children or the Elderly?
If you are PREGNANT
- FDB Only When Necessary: INSUFFICIENT HUMAN DATA AVAILABLE.
- FDB Only When Necessary:
If you are NURSING
- No Known Risk: AMOUNT EXCRETED REPORTED TO BE LOW WITH LOW INFANT ORAL BIOAVAILABILITY
- Precaution: INSUFFICIENT DATA AVAILABLE
If you are an adult over 60
- management or monitoring precaution: General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
Giving Emla 2.5 %-2.5 % Topical Cream to a child under 12
- management or monitoring precaution: Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- Severe Precaution: Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
- Severe Precaution: Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
- management or monitoring precaution: Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.